Population proteomics: the concept, attributes, and potential for cancer biomarker research.
about
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretionsMass spectrometry for translational proteomics: progress and clinical implicationsTop-down proteomics in health and disease: challenges and opportunitiesSerum peptidome variations in a healthy population: reference to identify cancer-specific peptidesDetection of venous thromboembolism by proteomic serum biomarkers.Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigensProteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.Liquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation.Fast proteomic protocol for biomarker fingerprinting in cancerous cells.Analysis of human blood plasma proteome from ten healthy volunteers from Indian populationMolecularly imprinted polymers coupled to matrix assisted laser desorption ionization mass spectrometry for femtomoles detection of cardiac troponin I peptides.In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.Mass spectrometry-based immunoassays for the next phase of clinical applications.Proteomics in atherothrombosis: a future perspective.Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies."Proteotyping": population proteomics of human leukocytes using top down mass spectrometry.High-throughput liquid-liquid fractionation of multiple protein post-translational modifications.Delineating Anopheles gambiae coactivator associated arginine methyltransferase 1 automethylation using top-down high resolution tandem mass spectrometry.Glycosylation status of vitamin D binding protein in cancer patients.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies.Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project.Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.Human proteoforms as new targets for clinical mass spectrometry protein tests.Different expression of S100A8 in malignant and benign gallbladder diseases.Protein biomarkers for subtyping breast cancer and implications for future research.Exploring the expression bar code of SAA variants for gastric cancer detection.Demonstration of sandwich and competitive modulated supraparticle fluoroimmunoassay applied to cardiac protein biomarker myoglobin.Predicting high-risk endometrioid carcinomas using proteins.
P2860
Q24628711-9E22310B-3805-4EC3-B7BF-28A2E15E5DB9Q26995497-2165BB91-3EEC-4814-A834-7A49DF55202CQ27002139-DCEB3D53-E42B-4FAE-9B22-F10F0E49F5A1Q28397855-CFE6D50F-0138-45FA-A0FF-25107A2C5838Q33288265-B589BED2-412A-42E6-813E-D7D0CB0970B9Q33289397-27BD3A70-5657-420B-A4AA-B47FC3D9C579Q33450135-9A5DC66D-8473-47AF-B25D-CF37E28536E9Q33457379-361C14E5-D6E7-4476-80BE-2B630116FDF2Q33798196-8FFEC0CE-14CC-4C9C-AFAD-FCC513570122Q34973952-A9D01FEE-7C7D-4C73-BE7B-64F13E0F23DFQ35776559-FDBAE54E-D366-488E-AFB9-D21A74BD62A2Q35925687-7A1227AC-8E84-461A-8DA5-F3756BC2BB28Q36088189-A47FEBC4-4525-4C9C-B863-AE02E773AA3CQ36689104-6B573D61-A41E-4EFC-989F-F3A34F2D4BE6Q36787244-7FB4B6B1-C68B-404F-AA17-73113B90655DQ36841893-EFB314B6-4670-404F-8EFE-1B49AE5C87EEQ37004146-C2BCDD5F-7A7B-4D1C-9785-C0868E6DA7A4Q37040674-306D9505-6A7E-4CFB-A844-D4FF109BC606Q37197072-D4B8BD87-D0F6-4A96-AA78-2289B861DC90Q37414479-A82BEE83-B2DE-4DCD-BB32-81C7F2240936Q37452925-4849BF81-F0A6-4CCE-A047-66B4843BF1C1Q37566426-0D6DE7A2-AA80-4934-AF3B-4EAB4BFA4C5FQ38018848-6C191D34-7810-4B49-8429-CD8FA1627390Q38068929-49340204-B28D-44EC-84C7-D8FAA663CDBFQ38179449-4B36F65F-0AE3-41B1-B650-63909C34F790Q38649742-A92CAA5D-F5D8-47BF-9E15-DC6C91A127C6Q43906599-E11EA049-1C4A-4C49-9DA9-EFAD434DE670Q47261659-47A89191-A641-4179-8BF2-F3B00BB4F38BQ48158874-D2C1FA10-7FAC-4D52-90B6-39711B9CD190Q51803210-B7138F45-13AC-4D14-8AE6-645AD9DFBBD5Q55368257-A622136B-CCB2-411B-BBBD-C0A9598E585A
P2860
Population proteomics: the concept, attributes, and potential for cancer biomarker research.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Population proteomics: the con ...... for cancer biomarker research.
@ast
Population proteomics: the con ...... for cancer biomarker research.
@en
type
label
Population proteomics: the con ...... for cancer biomarker research.
@ast
Population proteomics: the con ...... for cancer biomarker research.
@en
prefLabel
Population proteomics: the con ...... for cancer biomarker research.
@ast
Population proteomics: the con ...... for cancer biomarker research.
@en
P2093
P2860
P1476
Population proteomics: the con ...... for cancer biomarker research.
@en
P2093
Dobrin Nedelkov
Eric E Niederkofler
Kemmons A Tubbs
Randall W Nelson
Urban A Kiernan
P2860
P304
P356
10.1074/MCP.R600006-MCP200
P577
2006-05-30T00:00:00Z